Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q2 Virtual Investor Summit 2021
18 slides from Bioceres Crop Solutions's conference presentation, May 2021
Slide 1: Investor Presentation
Investor Presentation Investor Summit NASDAQ: BIOX May 2021
Slide 2: Disclaimer and Forward-looking Statement
Disclaimer and Forward-looking Statement This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a Financial Information Presentation solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other fina
Slide 3: Corporate Overview
Corporate Overview We are a fully-integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality A Compelling Biotech Story Grower- and consumer-oriented solutions Biotech platform with high-impact technologies around sustainable prod
Slide 4: History
History 43 years of experience utilizing multiple technological approaches to develop and commercialize products that enhance crop quality and productivity Regulatory approval for Bioceres HB4 wheat in consolidates Argentina 80% of Rizobacter Regulatory Digital platform HB4® soy Regulatory approval
Slide 5: Snapshot: Leading positions and multiple growth levers
Snapshot Leading positions and multiple growth levers By the Numbers Operational Revenue & Main Growth $177.0M 1st to achieve drought-tolerant wheat and soy Business Segments Gross Margin1 Lever Revenues¹ 23% market share in soybean biologicals CROP PROTECTION $92.2M | 42% Adjuvant expansion - Brazi
Slide 6: The HB4 Technology Performance
The HB4 Technology Performance Bioceres’ proprietary HB4 technology is the only available technology for drought tolerance in soy-wheat cropping systems EcoSoy EcoWheat CONTROL CONTROL +13% impact in yields +19.5% impact in yields 6
Slide 7: HB4 Value Creation to Growers
HB4 Value Creation to Growers Total addressable market Additional value created by HB41 Total Addressable Market2 Share of Total Market3 HIGH LOW 20-25M ha ~25-30% Soy HIGH LOW 2.5-3.0M ha ~30-35% Wheat 1 Analysis comprise average historical HB4 yield improvement extrapolated by county, for each cou
Slide 8: HB4 Market Access and regulatory status
HB4 Market Access and regulatory status FOOD & FEED PRODUCTION SUBMISSION APPROVAL SUBMISSION APPROVAL ARGENTINA 2014 2014 Regulatory approval in URUGUAY 2015 - 2015 - over 80% of the global soy market (AR, USA 2016 2016 BR and US) CHINA 2016 - - - BRAZIL 2018 2018 PARAGUAY 2018 2018 First approval
Slide 9: The Integrated Seed Product Concept
The Integrated Seed Product Concept GERMPLASM TRAITS HB4 Drought tolerance technology PEST CONTROL MOLECULES Customized microbial solutions POLYMER BIOLOGICALS Top tier germoplasm EXTERNAL FLOWABILITY Digital solutions AGENT 9
Slide 10: The HB4 Program Scalable sustainability
The HB4 Program Scalable sustainability Identity preserved production system to The Program establishes good agricultural multiply HB4 seeds with selected growers practices for growers, which enhanced by our technologies, significantly contribute to the transition of agriculture towards carbon neutr
Slide 11: HB4 Program
HB4 Program Inventory ramp-up on track; scaling rate ~25x-30x YoY1 ~7K Hectares Harvest 50 100% Customer repeat rate for Upcoming Season Sites $1.4M Contributed next cycle ~60K goods2 Hectares contractualized Wheat 58% Gross Margin 2 3 50% via beta version of Varieties digital platform Regions ~23K
Slide 12: Company Performance
Company Performance Proven track-record in delivering solid financial performance Revenues Adjusted EBITDA ($M) ($M) 176 173 161 47 46 134 41 87 22 14 FY17 FY18 FY19 FY20 3Q21 LTM FY17 FY18 FY19 FY20 3Q21 LTM Adjusted EBITDA Margin (%) 16 16 25 27 26 ¹ Financials presented correspond to As Reported
Slide 13: Debt Profile, Cash Position & Generation
Debt Profile, Cash Position & Generation Net Debt 2.30x 1.98x 2.12x 3.05x 2.89x LTM EBITDA $ million 97.9 134.2 Notes: 101.1 75.1 128.6 1) Net Debt = Total financial debt 103.5 less cash and cash equivalents. 80.0 84.3 2) Cash & Cash Equivalents include 93.4 92.0 $ 32.4M in other cash management sho
Slide 14: Main Corporate Entities
Main Corporate Entities 52% Bioceres Crop Public investors Solutions Corp and others 40,3M (BIOX) Outstanding shares Bioceres LLC 48%1 (NASDAQ: BIOX) (USA) 100% 80% 100% Rizobacter 9 international Bioceres S.A. (ARG) subsidiaries Semillas S.A. (ARG) 100% 50% Bolivia Colombia Brazil 50% USA Paraguay
Slide 15: Exhibits
” Y, 7 OCER ES ' CROP SOLUTIONS —
Slide 16: Unaudited Consolidated Statement of Comprehensive Income
Unaudited Consolidated Statement of Comprehensive Income Three-month period Three-month period Nine-month period Nine-month period ended 03/31/2021 ended 03/31/2020 ended 03/31/2021 ended 03/31/2020 Total revenue 36,221,113 25,672,412 127,315,064 124,918,358 Cost of sales (20,901,909) (14,920,088) (
Slide 17: Unaudited Consolidated Statement of Financial Position
Unaudited Consolidated Statement LIABILITIES 03/31/2021 06/30/2020 of Financial Position CURRENT LIABILITIES Trade and other payables 60,402,061 57,289,862 Borrowings 85,415,020 63,721,735 ASSETS 03/31/2021 06/30/2020 Employee benefits and social security 3,622,544 4,510,592 CURRENT ASSETS Deferred
Slide 18: Contact Us
Contact Us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com 18
Bioceres Crop Solutions — Q2 Virtual Investor Summit 2021 on 6ix